In a congressional hearing, alarming allegations were raised about inefficiencies, corruption, and negligence in the nation’s organ transplant system, with concerns about conflicts of interest on the board overseeing the system. Allegations of misconduct, including kickback schemes and patient safety issues, were discussed, highlighting the need for stronger oversight by the Health Resources and Services Administration (HRSA). Medicare reimbursement practices for organ procurement organizations were also criticized for potential misuse of funds. Access to organs and waitlist disparities, especially for minority and rural populations, were highlighted as ongoing challenges. Urgent reforms to improve transparency and accountability were called for by witnesses.
Source link
5 takeaways: Congress aims to fix troubled U.S. transplant system
